Home Latest Articles
Latest Articles
  • Cheng ZHANG, Dong YAN, Gang CHANG, Qianying LIU, Guangxi ZHAI
    Chinese Journal of Pharmaceuticals. 2023, 54(9): 1294-1301.

    As a novel drug delivery system, microspheres can provide a sustained-release drug delivery lasting from weeks to months, which reduce drug administration frequency and improve patient compliance. Poly(lactide-co-glycolide)(PLGA) has been widely used as a carrier material for microspheres manufacture. However, the molecular characteristics of PLGA are the key influence factors in the stage of formulation design, which are related to the pivotal behaviors of microspheres, such as drug loading, particle size and sustained-release properties. In this paper, by reviewing the recent studies on the preparation and evaluation of PLGA microspheres, five momentous molecular properties of PLGA(such as the relative molecular weight and distribution), which have significant effects on the properties of microspheres are screened out. The effects of each molecular property on the behaviors of microspheres are summarized and the reasons are explained, which provides a reference for the selection of PLGA type in the development of microspheres with expected properties.

  • Hua MA, Ning QIAO, Hongzhou SHANG, Xiaoran SUN, Xueli ZHANG
    Chinese Journal of Pharmaceuticals. 2023, 54(9): 1302-1309.

    Hollow mesoporous silica nanoparticles are inorganic porous materials with both hollow core and mesoporous shell structures. The hollow mesoporous silica nanoparticles are ideal drug carrier materials due to their hollow core structure which can improve the drug loading capacity and a large number of surface silanol groups which can be easily functionalized. This paper reviews the intelligent responsive drug delivery system constructed with hollow mesoporous silica nanoparticles as drug carriers, summarizes the research progress of endogenous stimuli(pH value, redox microenvironment, enzymes), exogenous stimuli(temperature, light, magnetism), and multi-stimuli responsive hollow mesoporous silica-based drug delivery system of antineoplastics, analyzes its biocompatibility and safety, and gives an outlook on its development.

  • Xiaoqian TAO, Jiabin SUN, Jingwen LEI, Lan CHENG, Chungang ZHANG
    Chinese Journal of Pharmaceuticals. 2023, 54(9): 1310-1318.

    Soft capsules may encounter a series of stability problems in the processes of production, transportation and storage, such as the adhesion, leakage and delayed disintegration, which greatly shorten the shelf-lives of soft capsules. High temperature, high humidity, ultraviolet radiation, γ-radiation, rapid drying and other physical conditions or exposing to aldehydes, ketones, imines and other chemical substances will cause cross-linking and aging of soft capsule shell, inducing above stability issues. Developing new types of soft capsule shell material might improve the aforementioned issues. In this review, new soft capsule shell materials are classified according to sources, the research progress of animal-, plant- and microbial-derived materials, as well as modified and synthetic shell materials are introduced, hoping to provide a reference for improving the stability of soft capsules during their shelf-lives.

  • Fangxi YANG, Yang GAO, Lei JIN, Zhenjun DU, Wencai HUANG
    Chinese Journal of Pharmaceuticals. 2023, 54(9): 1319-1322.

    Under the action of sulfuric acid, 2-[bis(4-methoxyphenyl)methyl]pyridine(4) was prepared by the condensation of 2-pyridinecarboxaldehyde(2) and anisole(3) in dichloromethane/acetic acid(with volume ratio of 4∶1), and amount of the isomer impurity in the product was controlled under 3%. Compound 4 was demethylated by methionine/methanesulfonic acid instead of traditional demethylation methods (such as hydrobromic acid) to obtain 4,4'-(pyridin-2-yl-methylene)diphenol(5). This step has the advantages of available raw materials, low corrosiveness, and short reaction time. Sodium picosulfate(1) was obtained by esterification and salt formation from 5 by solid sulfur trioxide pyridine, which had better stability and lower corrosiveness. The improved route was robust and simple with the total yield of 51.8%(based on 2) and the purity of 99.9%, which was more suitable for industrial production.

  • Naihua ZHANG, Yaqing WANG, Guanglong BAO, Anguo ZHU, Guimin ZHANG
    Chinese Journal of Pharmaceuticals. 2023, 54(9): 1323-1326.

    An improved synthetic process of 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylic acid(1), a key intermediate for the preparation of prucalopride succinate, was developed. Methyl 4-acetamido-5-chloro-2-(2-hydroxyethoxy)benzoate(3) was prepared by O-alkylation of the starting material methyl 4-acetamido-5-chloro-2-hydroxybenzoate(2) with ethylene carbonate in the presence of potassium carbonate. Then, compound 3 was transformed into methyl 4-acetamido-5-chloro-2,3-dihydrobenzofuran-7-carboxylate(4) by the intramolecular cyclization on exposure to boron trifluoride etherate. Finally, the target compound 1 was obtained from 4 via hydrolysis reaction with an overall yield of 76.0%(based on 2) and a purity of 99.8%. The optimized process was robust with simple operation, which was suitable for industrial production.

  • Wen ZHANG, Daopeng CHEN, Kang DU, Xiangping YANG, Xiangyang XU
    Chinese Journal of Pharmaceuticals. 2023, 54(9): 1327-1329.

    In this study, the key intermediate of aripiprazole, 7-hydroxy-3,4-dihydro-2(1H)-quinolone(1), was obtained by intramolecular Friedel-Crafts alkylation reaction of 3-chloro-N-(3-hydroxyphenyl)propionamide(4) using triethylamine hydrochloride-aluminum chloride ionic liquid. Compound 4 was synthesized by acylation reaction between m-aminophenol(2) and 3-chloropropionyl chloride(3). Through the optimization of the main process parameters, the reaction conditions of the Friedel-Crafts alkylation were confirmed as the following: the amount of substance ratio of 3-chloro-N-(3-hydroxyphenyl)propionamide, triethylamine hydrochloride and aluminum chloride was 1.1∶1.0∶5.5, and reaction temperature was 120 - 130 ℃, while reaction time was 10 h. Under the above conditions, the product was successfully scaled up to the kilogram scale. The purity of the product was up to 99.7% with the total yield of 58.2%(based on 2). This method had mild conditions, simple post-processing, high product purity, stable process, which was suitable for industrialization.

  • Zhibo ZHENG, Peng PENG, Ying LI, Jiangyuan HU, Fuli ZHANG, Chuanmeng ZHAO
    Chinese Journal of Pharmaceuticals. 2023, 54(9): 1330-1336.

    In the process of stability investigation of papaverine hydrochloride, 6 compounds were founded in forced degradation experiment. Among them, the related substances 1 - 4 were not indexed in pharmacopoeias.1-(3,4-Dimethoxybenzyl)-6-hydroxy-7-methoxyisoquinoline(related substance 1), 1-(3,4-dimethoxybenzyl)-6-methoxy-7-hydroxyisoquinoline(related substance 2), 1-(3-hydroxy-4-methoxybenzyl)-6,7-dimethoxyisoquinoline(related substance 3), and 1-(3-methoxy-4-hydroxybenzyl)-6,7-dimethoxyisoquinoline(related substance 4) were obtained via condensation, cyclization, reduction and dehydrogenation with the corresponding demethylamine or acid as starting materials. Besides, two compounds, as the impurities indexed in European pharmacopoeia, (6,7-dimethoxy-1-isoquinolyl)-(3,4-dimethoxyphenyl)ketone(IMP-D) and (6,7-dimethoxy-1-isoquinoline)-(3,4-dimethoxyphenyl)methanol(IMP-B) were synthesized. The structures of these 6 compounds were confirmed by 1H NMR, 13C NMR and HRMS.

  • Jiawei TANG, Hao CHEN, Luwen ZHANG, Rui ZHANG, Haiyan WU, Dong YI, Fuli ZHANG, Shaoxin CHEN
    Chinese Journal of Pharmaceuticals. 2023, 54(9): 1337-1344.

    Carbonyl reductases(CREDs) are valuable tools in the synthesis of chiral drugs. In this study, 96 CREDs from different sources were obtained by gene mining strategy, then cloned and expressed in Escherichia coli to construct CRED library 1.0. The catalytic performance of the enzyme library for eight substrates with different structures was investigated. The results showed that the catalytic performance of CREDs on various substrates with distinct structure was significantly different. Several enzymes with high catalytic activity were screened out from the enzyme library, such as K21, K42, K38 and K73, which can efficiently catalyze ethyl acetoacetate, 4-chloroacetoacetate ethyl ester, acetophenone and ethyl benzoylacetate, respectively. Later, the process development for the efficient preparation of optically chiral alcohol (S)-4-chloro-3-hydroxybutyrate(ee>99%) by carbonyl reductase K42 and K87, the synthesis of(R)-4-chloro-3-hydroxybutyrate(ee>99%) by K94 were successfully realized with a space-time yield of 800 g·(L·d)–1. The carbonyl reductase library 1.0 provided a new tool box for industrial synthesis of chiral drugs.

  • Yuhuan WU, Xinhua WEI, Meng CHENG, Canjian WANG, Guosong ZHANG
    Chinese Journal of Pharmaceuticals. 2023, 54(9): 1345-1353.

    Clarithromycin taste-masking granules were prepared by wet granulation and top-spray fluidized bed coating. The taste-masking granules and clarithromycin-Eudragit EPO solid dispersion prepared by co-precipitation were physically characterized by scanning electron microscopy, infrared spectroscopy, and X-ray powder diffraction. The results showed that the taste-masking granules had a rounded appearance, and the crystal form of clarithromycin in taste-masking granules had not changed. Furthermore, the taste-masking granules with different coating weights and solid dispersions in various pH media were investigated. The taste-masking granules with a coating weight gain of 18% were hardly dissolved in water but dissolved completely in a pH 1.2 medium within 15 min. Finally, electronic tongue, animal preference, and human sensory tests were applied to evaluate the taste masking effect. The results showed that the taste-masking granules well masked the bitter taste of clarithromycin, while masking effect of the solid dispersion was poor.

  • Juxiang WANG, Da ZHOU, Yongqiang SUN
    Chinese Journal of Pharmaceuticals. 2023, 54(9): 1354-1359.

    This study used styrene-isoprene-styrene(SIS) block copolymer as the matrix, liquid paraffin as carrier dispersant, hydrogenated petroleum resin as the tackifier, N-methyl pyrrolidone(NMP) as solubilizer, menthol as the penetration enhancer, citric acid as the acidity regulator and butylated hydroxytoluene(BHT) as the antioxidant to prepare loxoprofen sodium(1) transdermal patches. The preparation process was optimized by orthogonal design. The optimized formulation compositons of the patch were as follows: the mass fraction of SIS was 27%, liquid paraffin was 33%, hydrogenated petroleum resin was 26%, citric acid was 1.2%, menthol was 5.67%, and both NMP and BHT were 0.85%. The quality of 1 patch prepared according to the optimal formulation was stable, and the adhesive property was good. Its transdermal effect was equivalent to the reference preparation(the permeability per unit area at 24 h reached 72.69 μg).

News